The Claim

Red ginger extract fraction F6 reduces the release of pro-inflammatory cytokines TNF-α and IL-6 from macrophage cells in vitro.

Source: Bioactive substances from Red ginger rhizome (Zingiber officinale Roscoe var. sunti Val) as Anti-atherosclerotic agent: Inhibition of Lipoxygenase in arachidonic acid metabolism

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
46score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

A specific compound from red ginger decreases the production of TNF-α and IL-6 cytokines in human macrophage cells grown in laboratory cultures.

See the scientific wording

Red ginger extract fraction F6 reduces the release of pro-inflammatory cytokines TNF-α and IL-6 from macrophage cells in vitro, suggesting potential modulation of inflammatory signaling pathways.

Why this might work

Special compounds in red ginger block an enzyme that makes inflammatory fats, which stops immune cells from releasing chemicals that cause swelling and tissue damage.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Bioactive substances from Red ginger rhizome (Zingiber officinale Roscoe var. sunti Val) as Anti-atherosclerotic agent: Inhibition of Lipoxygenase in arachidonic acid metabolism

    In a lab test, a special part of red ginger called fraction F6 made immune cells produce less of two chemicals (TNF-α and IL-6) that cause inflammation. This means it might help calm down inflammation.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.